Cutera reiterated at outperform by RBC

Cutera, Inc. was reiterated at outperform, speculative risk, with a 12-month price target of $36 by RBC Capital Markets analyst Phil Nalbone. The company's third-quarter sales of $25.1 million was "spot on" with the analyst's estimates. Third-quarter earnings per share of $0.30 beat Nalbone's estimate by 2 cents and the Street estimate by 1 cent. Cutera also generated $7.7 million in cash flow from operations and ended the quarter with $90.7 million in cash and no debt. Shares of the Brisbane, Calif.-based medical device company were up $3.18, or 11.89%, at $26.93. (Nasdaq: CUTR)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.